A Limb Salvage Program

For clinics already evaluating neuropathy, the DTC Amputation Prevention Program™ creates a natural next step. It helps move the clinic beyond nerve testing alone by connecting neuropathy findings to a broader lower-extremity prevention pathway that may include vascular testing, wound-risk review, balance assessment, therapy referral, monitoring, care planning, wound-care support, or referral when clinically appropriate.

Amputation prevention begins before the wound. It begins when hidden lower-extremity risk signals are identified, documented, tested when appropriate, and connected to timely clinical action. For many patients, the earliest warning signs may appear as numbness, tingling, burning, foot pain, cold feet, balance changes, reduced walking tolerance, weakness, skin changes, poor healing, or functional decline. These symptoms may suggest that nerve, vascular, balance, wound-risk, or mobility-related concerns are already developing.

The Neuropathy Clinic serves as the front door to this prevention pathway. By identifying neuropathy and related lower-extremity risk earlier, the clinic can help providers better document medical necessity, close care gaps, and intervene before silent risk becomes a wound, infection, hospitalization, or preventable limb loss.

The program begins with TriageIQ™, DTC’s multi-domain pre-screener. TriageIQ™ helps capture patient-reported risk signals at intake, before or during the visit, so providers can better recognize when focused testing, assessment, therapy, monitoring, wound-care support, or referral may be clinically appropriate.

Start with the signal. Protect the limb. Preserve independence. The DTC Amputation Prevention Program™ is a structured lower-extremity risk pathway designed to help Neuropathy Clinics identify, document, and act on early warning signs before they progress into serious diabetic foot complications, wounds, infection, hospitalization, or preventable amputation.

From TriageIQ™ to Lower-Extremity Testing

Within the Neuropathy Clinic, TriageIQ™ helps identify patient-reported lower-extremity risk signals before or during the visit. When these signals are present, the provider may determine whether additional focused testing, assessment, monitoring, therapy, wound-care support, or referral is clinically appropriate.

Depending on the patient’s reported symptoms, medical history, and clinical presentation, follow-up may include Diabetic Neuropathy Device™ (DND) testing, TruPAD™ vascular testing, balance testing, wound-risk review, neuropathy therapy, vascular therapy, care-management coordination, foot-care education, or referral.

This creates a practical pathway from intake to action. Rather than waiting for a serious foot complication to appear, the Neuropathy Clinic is given an earlier opportunity to evaluate whether nerve, circulation, balance, wound-risk, or mobility-related concerns may already be developing.

Neuropathy Testing. The Diabetic Neuropathy Device™ (DND) may be used when a patient presents with neuropathy-related signals such as numbness, tingling, burning, altered sensation, foot pain, balance concerns, reduced protective sensation, or diabetes-related lower-extremity risk.

Neuropathy testing is important because nerve dysfunction can reduce a patient’s ability to feel pain, pressure, injury, temperature changes, or early tissue damage. When protective sensation is impaired, a patient may not recognize a blister, wound, pressure point, or foot injury until it becomes more serious.

DND testing may help providers evaluate small-fiber and large-fiber neuropathy risk, strengthen documentation, and determine whether the patient may be appropriate for additional follow-up, balance testing, neuropathy therapy, foot-care education, wound-risk review, monitoring, or referral.

Vascular Testing. TruPAD™ may be used when TriageIQ™ or the clinical encounter identifies possible circulation-related signals such as leg pain with walking, reduced walking tolerance, cold feet, poor healing, skin discoloration, diminished pulses, diabetes-related vascular risk, cardiovascular history, or suspected peripheral artery disease.

Vascular testing is important because impaired circulation can reduce the body’s ability to heal. When blood flow is limited, even a small foot injury may become harder to recover from. When neuropathy and vascular disease overlap, the risk becomes more serious because the patient may not feel an injury early and may not heal properly once an injury occurs.

Objective vascular testing helps providers better understand circulation risk and determine whether vascular therapy, monitoring, wound-care coordination, referral, or additional follow-up may be clinically appropriate.

Balance, Wound-Care, and Therapy Readiness. Lower-extremity risk is not limited to neuropathy or circulation alone. Patients with nerve dysfunction, pain, weakness, reduced sensation, or impaired vascular function may also experience gait changes, balance concerns, fall risk, reduced mobility, and functional decline.

When TriageIQ™ identifies signals related to balance, walking difficulty, pain, weakness, falls, wound risk, or poor healing, the patient may be appropriate for additional assessment or clinical support. This may include balance testing, wound-care review, neuropathy therapy, vascular therapy, foot-care education, or care-management coordination.

The goal is to help the Neuropathy Clinic identify risk earlier, support stronger documentation, and guide the patient toward the right next step before lower-extremity complications become more advanced.